Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204, (S0165032722011818), (10.1016/j.jad.2022.09.168)]

Kwonmok Ko*, Emma I. Kopra, Anthony J. Cleare, James J. Rucker

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors wish to express their regret regarding an error in the publication of the original article. In Table 3, titled “Psilocybin studies on depressive disorders,” specifically in the fourth row related to the study conducted by Carhart-Harris et al. (2016), the main results column inaccurately presented the Cohen's d figure, which included data from Carhart-Harris et al. (2018) that pertained to eight additional participants, data which were not analyzed in Carhart-Harris et al. (2016). For the sake of clarity and accuracy, the corrected version should read as follows: 1-week: marked reduction in QIDS (Hedges' g = 3.1, p = .002) 5-week: marked reduction in QIDS (Hedges' g = 2.7, p = .003); response and remission rate at 45 % and 20 % 3-month: reduction in QIDS remained positive (Hedges' g = 2.0, p = .003). The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)409
Number of pages1
JournalJournal of Affective Disorders
Volume348
DOIs
Publication statusPublished - 1 Mar 2024

Fingerprint

Dive into the research topics of 'Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204, (S0165032722011818), (10.1016/j.jad.2022.09.168)]'. Together they form a unique fingerprint.

Cite this